Jawline Contouring Without Surgery: Filler, Masseter Botox, Kybella and More

A jawline can read as soft or round for four different reasons, and each reason points to a different treatment category.

The FDA approvals and labels themselves describe what each treatment changes, so reading them is the clearest map.

Fat is the first driver.

The American Academy of Dermatology (AAD) describes the treatable bulge as a small pocket of fat that remains despite diet and exercise, in someone whose weight is in the normal range for their height — and it says outright that these treatments are not a weight-loss method.

Skin is the second.

The Kybella label tells providers to weigh the risks where there is excess skin laxity — loose skin — or prominent platysmal bands, the vertical bands of the neck muscle, because it says results may not look good there.

Muscle is the third.

Botulinum toxin jaw slimming — an off-label use for every US toxin, as the next sections cover — targets the masseter, the chewing muscle at the back of the jaw.

Definition is the fourth, and the labels name it directly: two fillers carry approvals whose own wording is loss of jawline definition and loss of jawline contour.

Because the drivers differ, the categories are not interchangeable: Kybella's approval covers under-chin fat, the tightening category's best candidates are people with only a small amount of sagging skin, and the filler approvals name lost definition or contour.

Fullness under the chin specifically has its own concern page — see our double chin guide.

Filler is the category with direct FDA approvals for this area.

The FDA approves dermal fillers for adults 22 and older for specific areas only, and says it may not have reviewed use of a product elsewhere.

As of 2026-10-20, two US fillers carry FDA-approved jawline indications:

• Juvéderm Volux XC is approved (PMA P110033/S065, 29 Jul 2022) to improve jawline definition in adults over 21 with moderate to severe loss of jawline definition.
• Radiesse (+) is approved (PMA P050052/S129, 1 Sep 2021) for deep injection to improve moderate to severe loss of jawline contour in adults over 21.

Adjacent areas matter to a contouring plan too.

Juvéderm Voluma XC is approved for cheek augmentation for age-related midface volume loss and for chin augmentation (S047, 12 Jun 2020), and separately for moderate to severe temple hollowing in adults over 21 (S070, 6 Oct 2023). Restylane Lyft with Lidocaine is approved for chin augmentation in mild to moderate chin retrusion — a chin that sits back (P040024/S142, 4 Nov 2025) — and Restylane Contour was approved for temple hollowing in patients over 21 (P140029/S054, 20 Mar 2026).

How long jawline filler lasts depends on the material.

AAD's duration table gives hyaluronic acid 4 to 12 months and calcium hydroxylapatite 6 months to 1 year, while the FDA's filler page gives HA about 6 to 12 months and CaHA about 18 months — the two sources disagree, and duration varies by product and area.

Product-by-product detail, placement and price are in our jawline filler guide, and the chin specifically in our chin filler guide.

Botulinum toxin to slim the masseter is off-label for every US toxin on the market: no toxin label includes the masseter.

Botox Cosmetic's cosmetic label covers moderate to severe frown lines, crow's feet, forehead lines and — since October 2024 — platysma bands, the vertical neck bands.

The masseter is not on that list, and neither is the jawline.

Off-label here means the label gives no dose, no results and no duration for the masseter.

The 3 to 4 months stated on Botox Cosmetic's label is a frown-line figure; there is no label duration to quote for the masseter, so any month count you see for jaw slimming is an estimate rather than a labeled one.

What a masseter treatment involves, how it is studied and what it costs are in our masseter botox guide.

Under-chin fat has two non-surgical treatments, and both are tied to specific areas and body-mass limits.

Kybella (deoxycholic acid) is a prescription drug approved only for moderate to severe fullness from submental — under-the-chin — fat in adults.

Its label says it is not approved for fat outside the submental region and that such use is not recommended, so fat in the jowls or elsewhere is outside the approval.

AAD's session counts for non-invasive fat reduction put chin-fat injections at usually 2 sessions spaced 6 to 8 weeks apart — AAD's figure for this class of treatment — and cryolipolysis (fat freezing) at usually 2 sessions.

Kybella's own label schedule is different: up to 6 single treatments, at least 1 month apart.

Device results start as early as 3 weeks, with full effect 3 to 6 months after the last treatment.

AAD adds that some people are extremely swollen for as long as 2 weeks after chin-fat injections, though they can return to normal activities, and that full results show about 3 to 4 months after the last treatment.

CoolSculpting Elite is an FDA-cleared device — 510(k) K233732, 12 Sep 2024 — for cold-assisted fat breakdown of the submental and submandibular areas (under the chin and jaw) with a BMI up to 46.2.

Its clearances for the upper arm, bra fat, back fat, banana roll, thigh, abdomen and flanks apply at a BMI of 30 or less.

Kybella's pivotal trials enrolled adults aged 19 to 65 with a BMI of 40 or less.

Neither is a weight-loss treatment by AAD's framing: its guidance, which covers fat-freezing devices and chin-fat injections alike, describes good candidates as people with a small bulge of fat that remains despite diet and exercise and a weight in the normal range for their height, and says outright it is not a weight-loss method.

What the treatment destroys does not come back, but AAD notes the remaining fat cells in the area can still expand with weight gain.

It also notes, rarely, fat freezing can cause long-term pain or increase the amount of fat in the treated area — a condition called paradoxical adipose hyperplasia.

The full treatment courses, session detail and prices are in our kybella and coolsculpting guides.

Where the issue is loose skin along the jaw edge — jowls — rather than fat or volume, tightening is the category.

AAD's comparison is blunt: a surgical lift gives the most dramatic results, while non-invasive tightening with ultrasound, radiofrequency or some lasers gives modest tightening and lifting with little or no recovery time.

Modest is the operative word — AAD's own comparison gives the most dramatic results to surgery.

AAD's ultrasound timeline: with one treatment, most people see modest lifting within 2 to 6 months.

Radiofrequency is usually 1 treatment, with best results at about 6 months, lasting 2 to 3 years with good skin care.

Non-wounding lasers need 3 to 5 treatments, with results 2 to 6 months after the last.

What each device is actually cleared to do under the jaw differs:

• Sofwave is FDA-cleared (510(k) K250146, 18 Apr 2025) to improve facial lines and wrinkles, lift the eyebrow, and lift lax submental and neck tissue in people aged 22 and older.
• Ultherapy and Sofwave both carry clearances to "lift" lax submental and neck tissue. Thermage FLX's clearance is for wrinkles and rhytids, not "lift."
• Morpheus8's current 510(k) (K231790, 20 Jul 2023) covers dermatologic procedures where coagulation or contraction of soft tissue, or hemostasis, is needed — the cleared indication text does not mention skin tightening of the jowls.

AAD's picture of the best candidates: only a small amount of sagging, a stable healthy weight, no smoking and sun protection.

With a lot of sagging skin, tightening may not help, and it is not for anyone pregnant or with a skin infection.

Device-by-device detail, results and prices are in our sofwave and morpheus8 guides.

In the approval and clearance wording we checked for this page, we found no sex-specific indication.

The jawline filler approvals are for adults over 21, the FDA's filler age floor is 22 and older, CoolSculpting's under-chin clearance is set by area and BMI, and Kybella's approval is for adults.

Dosing does not differ on paper either: Botox Cosmetic's label has no separate higher dose for men on its labeled areas, and the masseter has no label dose at all, for anyone, because it is off-label there.

The broad numbers we found are surgical ones, and they come with scope.

In ASPS's 2025 statistics, men accounted for 89,617 cosmetic surgical procedures versus 1,431,257 for women — about 6% of cosmetic surgery by ASPS members.

That is plastic-surgeon surgery data, not the share of med spa patients who are men, which our research found no public primary figure for.

What differs in practice is the goal a person brings to the consult — more definition, less width, or a sharper angle under the ear — and that is a conversation with a licensed provider, not a label question.

Because the drivers stack, plans often stack too: filler for structure, toxin for the muscle, fat reduction for the under-chin, tightening for the skin.

One data gap matters before combining.

The FDA says the safety of fillers used in combination with neuromodulators ("Botox") or other treatments has not been evaluated in a controlled clinical study.

The results also land on different clocks, which is worth knowing before you book.

Most fillers show results immediately, though poly-L-lactic acid (Sculptra) takes 2 to 3 weeks and builds from there.

Fat-reduction devices can start at 3 weeks, with full effect 3 to 6 months after the last treatment, and Kybella's full results show about 3 to 4 months after the last.

Radiofrequency tightening's best results come at about 6 months.

Each category is priced differently: filler by the amount used — effectively per syringe — neurotoxin by the unit or the treatment area, Kybella by the session or the vial, and energy devices by the session, the cycle or a package.

What a plan costs comes down to how many syringes, units or sessions it needs, so ask a practice to price the plan rather than one treatment.

We list no invented averages here; the pricing structures are in our Kybella cost, masseter Botox cost and CoolSculpting cost guides.

The treatments on this page include prescription injections and cleared devices.

For the toxin among them, who may inject is a state-law question: AmSpa, the industry's trade association, describes injecting botulinum toxin — a prescription drug — as the practice of medicine, to be done by a physician, an independent-practice nurse practitioner or another licensed professional working within their scope, under rules that vary by state.

MedSpaStandard's med spa directory and its treatment-by-city listings are not live yet, so we cannot point you to a vetted clinic here.

Until it ships, AAD's questions to ask before any cosmetic procedure are the filter to run on the phone or in the consult: Is the provider board-certified?

How many times have they done this exact procedure?

How often do they treat patients with your skin tone and type?

What results can you realistically expect — ask for before-and-after photos of people with similar skin tones?

And what are the risks, recovery time, number of treatments and cost?

For the wider map of concerns and treatments, start from our skin and body concerns section, and read our guides to how to choose a med spa and med spa injector credentials before you book anywhere.